EMULATE THERAPEUTICS

EMulate Therapeutics is a clinical-stage therapeutic device company headquartered in Seattle, Washington. Founded in 2002, the company employs 13 people. EMulate Therapeutics specializes in developing and commercializing a groundbreaking technology called ulRFE® (ultra-low radio frequency energy). This proprietary technology uses precisely targeted, non-invasive energy to regulate signaling and metabolic pathways at the molecular and genetic levels. The company's flagship product, the EMulate Therapeutics Voyager, delivers ulRFE® therapy in a simple-to-use device. The company's initial focus is on treating brain cancer patients who haven't responded well to traditional therapies. EMulate Therapeutics believes ulRFE® has the potential to be applied to a wide range of conditions, including oncology and pain treatment, as well as veterinary medicine and non-medical applications. For more information about EMulate Therapeutics and its innovative ulRFE® technology, visit their website at emulatetx.com.